annual EBITDA:
-$120.46M+$209.88M(+63.53%)Summary
- As of today (May 21, 2025), PTCT annual EBITDA is -$120.46 million, with the most recent change of +$209.88 million (+63.53%) on December 31, 2024.
- During the last 3 years, PTCT annual EBITDA has risen by +$247.72 million (+67.28%).
- PTCT annual EBITDA is now -460.09% below its all-time high of $33.45 million, reached on December 31, 2011.
Performance
PTCT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$971.14M+$1.02B(+2171.77%)Summary
- As of today (May 21, 2025), PTCT quarterly EBITDA is $971.14 million, with the most recent change of +$1.02 billion (+2171.77%) on March 1, 2025.
- Over the past year, PTCT quarterly EBITDA has increased by +$959.61 million (+8320.54%).
- PTCT quarterly EBITDA is now at all-time high.
Performance
PTCT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$839.14M+$959.61M(+796.60%)Summary
- As of today (May 21, 2025), PTCT TTM EBITDA is $839.14 million, with the most recent change of +$959.61 million (+796.60%) on March 1, 2025.
- Over the past year, PTCT TTM EBITDA has increased by +$1.09 billion (+430.41%).
- PTCT TTM EBITDA is now at all-time high.
Performance
PTCT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PTCT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.5% | +8320.5% | +430.4% |
| 3 y3 years | +67.3% | +1447.6% | +343.4% |
| 5 y5 years | +38.3% | +1095.1% | +463.8% |
PTCT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.3% | at high | +718.3% | at high | +297.6% |
| 5 y | 5-year | at high | +67.3% | at high | +685.9% | at high | +297.6% |
| alltime | all time | -460.1% | +67.3% | at high | +685.9% | at high | +297.6% |
PTCT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $971.14M(-2171.8%) | $839.14M(-796.6%) |
| Dec 2024 | -$120.46M(-63.5%) | -$46.88M(-6.1%) | -$120.46M(+14.0%) |
| Sep 2024 | - | -$49.90M(+41.6%) | -$105.66M(-20.0%) |
| Jun 2024 | - | -$35.23M(-405.4%) | -$132.14M(-48.0%) |
| Mar 2024 | - | $11.53M(-136.0%) | -$253.97M(-23.1%) |
| Dec 2023 | -$330.34M(-10.2%) | -$32.07M(-58.0%) | -$330.34M(-22.2%) |
| Sep 2023 | - | -$76.38M(-51.4%) | -$424.60M(+1.1%) |
| Jun 2023 | - | -$157.06M(+142.2%) | -$420.07M(+16.5%) |
| Mar 2023 | - | -$64.83M(-48.7%) | -$360.55M(-2.0%) |
| Dec 2022 | -$367.78M(-0.1%) | -$126.33M(+75.8%) | -$367.78M(+8.6%) |
| Sep 2022 | - | -$71.85M(-26.3%) | -$338.75M(-6.4%) |
| Jun 2022 | - | -$97.54M(+35.4%) | -$362.00M(+5.0%) |
| Mar 2022 | - | -$72.06M(-25.9%) | -$344.80M(-6.4%) |
| Dec 2021 | -$368.18M(+21.5%) | -$97.30M(+2.3%) | -$368.19M(+24.4%) |
| Sep 2021 | - | -$95.11M(+18.4%) | -$295.92M(+37.3%) |
| Jun 2021 | - | -$80.34M(-15.8%) | -$215.53M(-28.4%) |
| Mar 2021 | - | -$95.44M(+281.4%) | -$300.95M(-0.7%) |
| Dec 2020 | -$303.09M(+55.2%) | -$25.03M(+70.0%) | -$303.09M(-8.3%) |
| Sep 2020 | - | -$14.72M(-91.1%) | -$330.36M(-9.5%) |
| Jun 2020 | - | -$165.75M(+69.9%) | -$365.17M(+58.3%) |
| Mar 2020 | - | -$97.59M(+86.6%) | -$230.65M(+18.1%) |
| Dec 2019 | -$195.25M(+118.2%) | -$52.29M(+5.6%) | -$195.25M(+7.8%) |
| Sep 2019 | - | -$49.53M(+58.6%) | -$181.20M(+4.8%) |
| Jun 2019 | - | -$31.24M(-49.8%) | -$172.82M(+22.6%) |
| Mar 2019 | - | -$62.19M(+62.6%) | -$140.94M(+57.5%) |
| Dec 2018 | -$89.47M | -$38.24M(-7.1%) | -$89.47M(+124.6%) |
| Sep 2018 | - | -$41.16M(-6461.2%) | -$39.84M(+106.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $647.00K(-106.0%) | -$19.28M(-39.0%) |
| Mar 2018 | - | -$10.72M(-194.1%) | -$31.59M(-32.2%) |
| Dec 2017 | -$46.61M(-63.8%) | $11.39M(-155.3%) | -$46.61M(-43.3%) |
| Sep 2017 | - | -$20.60M(+76.6%) | -$82.18M(-11.5%) |
| Jun 2017 | - | -$11.66M(-54.7%) | -$92.83M(-20.6%) |
| Mar 2017 | - | -$25.74M(+6.5%) | -$116.92M(-9.2%) |
| Dec 2016 | -$128.77M(-21.6%) | -$24.18M(-22.6%) | -$128.77M(-15.3%) |
| Sep 2016 | - | -$31.25M(-12.6%) | -$151.99M(-6.3%) |
| Jun 2016 | - | -$35.74M(-4.9%) | -$162.21M(-1.3%) |
| Mar 2016 | - | -$37.59M(-20.7%) | -$164.41M(+0.1%) |
| Dec 2015 | -$164.25M(+69.0%) | -$47.40M(+14.3%) | -$164.25M(+10.6%) |
| Sep 2015 | - | -$41.47M(+9.3%) | -$148.54M(+10.7%) |
| Jun 2015 | - | -$37.94M(+1.3%) | -$134.12M(+10.9%) |
| Mar 2015 | - | -$37.44M(+18.1%) | -$120.99M(+24.5%) |
| Dec 2014 | -$97.18M(+126.0%) | -$31.69M(+17.1%) | -$97.18M(+17.1%) |
| Sep 2014 | - | -$27.06M(+9.1%) | -$83.00M(+39.2%) |
| Jun 2014 | - | -$24.81M(+82.1%) | -$59.63M(+22.5%) |
| Mar 2014 | - | -$13.62M(-22.2%) | -$48.67M(+13.2%) |
| Dec 2013 | -$43.00M(+78.4%) | -$17.51M(+374.9%) | -$43.00M(+39.3%) |
| Sep 2013 | - | -$3.69M(-73.4%) | -$30.87M(-8.0%) |
| Jun 2013 | - | -$13.86M(+74.3%) | -$33.57M(+35.5%) |
| Mar 2013 | - | -$7.95M(+47.8%) | -$24.77M(+11.1%) |
| Dec 2012 | -$24.10M(-172.1%) | -$5.38M(-15.8%) | -$22.29M(+31.8%) |
| Sep 2012 | - | -$6.39M(+26.5%) | -$16.91M(+60.7%) |
| Jun 2012 | - | -$5.05M(-7.7%) | -$10.52M(+92.3%) |
| Mar 2012 | - | -$5.47M | -$5.47M |
| Dec 2011 | $33.45M | - | - |
FAQ
- What is PTC Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for PTC Therapeutics?
- What is PTC Therapeutics annual EBITDA year-on-year change?
- What is PTC Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for PTC Therapeutics?
- What is PTC Therapeutics quarterly EBITDA year-on-year change?
- What is PTC Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for PTC Therapeutics?
- What is PTC Therapeutics TTM EBITDA year-on-year change?
What is PTC Therapeutics annual EBITDA?
The current annual EBITDA of PTCT is -$120.46M
What is the all time high annual EBITDA for PTC Therapeutics?
PTC Therapeutics all-time high annual EBITDA is $33.45M
What is PTC Therapeutics annual EBITDA year-on-year change?
Over the past year, PTCT annual EBITDA has changed by +$209.88M (+63.53%)
What is PTC Therapeutics quarterly EBITDA?
The current quarterly EBITDA of PTCT is $971.14M
What is the all time high quarterly EBITDA for PTC Therapeutics?
PTC Therapeutics all-time high quarterly EBITDA is $971.14M
What is PTC Therapeutics quarterly EBITDA year-on-year change?
Over the past year, PTCT quarterly EBITDA has changed by +$959.61M (+8320.54%)
What is PTC Therapeutics TTM EBITDA?
The current TTM EBITDA of PTCT is $839.14M
What is the all time high TTM EBITDA for PTC Therapeutics?
PTC Therapeutics all-time high TTM EBITDA is $839.14M
What is PTC Therapeutics TTM EBITDA year-on-year change?
Over the past year, PTCT TTM EBITDA has changed by +$1.09B (+430.41%)